$4.18 Billion is the total value of Redmile Group, LLC's 64 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 54.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $293,119,000 | +80.6% | 4,709,498 | -1.5% | 7.01% | +29.1% |
| ALLK | Sell | ALLAKOS INC | $289,277,000 | +19.6% | 3,033,526 | -1.4% | 6.92% | -14.5% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $245,545,000 | +34.3% | 25,209,964 | +10.6% | 5.87% | -4.0% |
| FATE | FATE THERAPEUTICS INC | $219,513,000 | +26.0% | 11,216,809 | 0.0% | 5.25% | -9.9% | |
| EPZM | Buy | EPIZYME INC | $215,152,000 | +141.5% | 8,746,033 | +1.3% | 5.15% | +72.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $185,117,000 | +50.3% | 1,153,232 | +6.7% | 4.43% | +7.5% |
| QURE | Buy | UNIQURE NV | $182,971,000 | +92.9% | 2,553,325 | +5.9% | 4.38% | +37.8% |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $149,132,000 | +568.5% | 2,722,388 | +244.6% | 3.57% | +377.5% |
| BIIB | New | BIOGEN INC | $135,754,000 | – | 457,500 | +100.0% | 3.25% | – |
| IGMS | IGM BIOSCIENCES INC | $119,975,000 | +115.0% | 3,144,000 | 0.0% | 2.87% | +53.6% | |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $115,593,000 | +1.2% | 1,800,800 | -20.1% | 2.76% | -27.7% |
| NVRO | Buy | NEVRO CORP | $110,389,000 | +99.4% | 939,164 | +45.9% | 2.64% | +42.5% |
| FTSV | Buy | FORTY SEVEN INC | $109,088,000 | +944.0% | 2,770,842 | +70.3% | 2.61% | +645.4% |
| APRE | New | APREA THERAPEUTICS INC | $104,111,000 | – | 2,268,718 | +100.0% | 2.49% | – |
| RGNX | Buy | REGENXBIO INC | $102,769,000 | +22.2% | 2,508,386 | +6.2% | 2.46% | -12.7% |
| CNC | Buy | CENTENE CORP DEL | $97,612,000 | +178.4% | 1,552,598 | +91.6% | 2.34% | +99.1% |
| TCDA | Buy | TRICIDA INC | $80,352,000 | +25.3% | 2,129,100 | +2.5% | 1.92% | -10.4% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $76,562,000 | +20.0% | 4,648,570 | +2.9% | 1.83% | -14.3% |
| IMGN | Buy | IMMUNOGEN INC | $74,737,000 | +111.3% | 14,639,960 | +0.2% | 1.79% | +51.0% |
| BSX | New | BOSTON SCIENTIFIC CORP | $73,763,000 | – | 1,631,200 | +100.0% | 1.76% | – |
| TNDM | Buy | TANDEM DIABETES CARE INC | $69,877,000 | +2.1% | 1,172,232 | +1.0% | 1.67% | -27.0% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $63,880,000 | – | 3,237,700 | +100.0% | 1.53% | – |
| KRYS | Buy | KRYSTAL BIOTECH INC | $60,375,000 | +61.2% | 1,090,200 | +1.1% | 1.44% | +15.2% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $59,707,000 | +28197.2% | 203,100 | +20816.6% | 1.43% | +20300.0% |
| NVS | New | NOVARTIS A Gsponsored adr | $54,267,000 | – | 573,100 | +100.0% | 1.30% | – |
| PRAH | Buy | PRA HEALTH SCIENCES INC | $49,995,000 | +27.4% | 449,800 | +13.8% | 1.20% | -8.9% |
| AXNX | Buy | AXONICS MODULATION TECH INC | $42,452,000 | +94.8% | 1,532,000 | +89.2% | 1.02% | +39.2% |
| HCA | Buy | HCA HEALTHCARE INC | $42,155,000 | +48.6% | 285,200 | +21.1% | 1.01% | +6.2% |
| PTCT | New | PTC THERAPEUTICS INC | $41,283,000 | – | 859,526 | +100.0% | 0.99% | – |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $40,241,000 | +21.2% | 701,178 | -24.0% | 0.96% | -13.3% |
| REPL | Buy | REPLIMUNE GROUP INC | $39,698,000 | +29.0% | 2,766,407 | +25.0% | 0.95% | -7.8% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $38,761,000 | +51.6% | 2,940,889 | +2.9% | 0.93% | +8.3% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $38,243,000 | -54.0% | 639,095 | -78.4% | 0.92% | -67.1% |
| ANTM | New | ANTHEM INC | $30,445,000 | – | 100,800 | +100.0% | 0.73% | – |
| GH | New | GUARDANT HEALTH INC | $30,451,000 | – | 389,700 | +100.0% | 0.73% | – |
| AMED | Buy | AMEDISYS INC | $30,223,000 | +9841.8% | 181,065 | +7704.5% | 0.72% | +7130.0% |
| CI | New | CIGNA CORP NEW | $30,162,000 | – | 147,500 | +100.0% | 0.72% | – |
| ARDX | New | ARDELYX INC | $30,020,000 | – | 4,000,000 | +100.0% | 0.72% | – |
| STOK | Buy | STOKE THERAPEUTICS INC | $28,908,000 | +32.2% | 1,020,778 | +0.3% | 0.69% | -5.6% |
| GRTS | Buy | GRITSTONE ONCOLOGY INC | $27,956,000 | +4.3% | 3,116,594 | +0.4% | 0.67% | -25.4% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $26,662,000 | -59.1% | 3,326,493 | +4.7% | 0.64% | -70.8% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $25,835,000 | -2.5% | 1,164,002 | -0.0% | 0.62% | -30.2% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $25,692,000 | -4.5% | 1,799,188 | +0.5% | 0.62% | -31.7% |
| ODT | Buy | ODONATE THERAPEUTICS INC | $25,638,000 | +27.3% | 790,071 | +2.1% | 0.61% | -9.1% |
| SWAV | New | SHOCKWAVE MED INC | $24,942,000 | – | 567,900 | +100.0% | 0.60% | – |
| NLTX | New | NEOLEUKIN THERAPEUTICS INC | $23,665,000 | – | 1,920,831 | +100.0% | 0.57% | – |
| HOOK | Sell | HOOKIPA PHARMA INC | $23,146,000 | +62.6% | 1,892,521 | -0.3% | 0.55% | +16.4% |
| XERS | XERIS PHARMACEUTICALS INC | $21,155,000 | -28.3% | 3,000,641 | 0.0% | 0.51% | -48.7% | |
| GMAB | Sell | GENMAB A Ssponsored ads | $20,917,000 | -17.3% | 936,700 | -25.0% | 0.50% | -41.0% |
| CABA | New | CABALETTA BIO INC | $20,001,000 | – | 1,431,696 | +100.0% | 0.48% | – |
| BCEL | Sell | ATRECA INC | $17,586,000 | +26.1% | 1,136,806 | -0.2% | 0.42% | -9.9% |
| STXS | Sell | STEREOTAXIS INC | $16,766,000 | +45.4% | 3,169,308 | -3.5% | 0.40% | +3.9% |
| GTHX | Buy | G1 THERAPEUTICS INC | $16,221,000 | +82.2% | 613,734 | +57.0% | 0.39% | +30.2% |
| CYRX | New | CRYOPORT INC | $13,865,000 | – | 842,363 | +100.0% | 0.33% | – |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $12,737,000 | -2.8% | 425,700 | +0.4% | 0.30% | -30.4% |
| VAPO | VAPOTHERM INC | $11,668,000 | +28.4% | 959,539 | 0.0% | 0.28% | -8.2% | |
| GLYC | Sell | GLYCOMIMETICS INC | $7,109,000 | -17.4% | 1,343,845 | -32.7% | 0.17% | -41.0% |
| BNTX | New | BIONTECH SEsponsored ads | $5,878,000 | – | 173,500 | +100.0% | 0.14% | – |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,515,000 | -65.4% | 2,813,565 | -9.7% | 0.13% | -75.3% |
| GOSS | Sell | GOSSAMER BIO INC | $4,068,000 | -7.0% | 260,300 | -0.1% | 0.10% | -33.6% |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $1,467,000 | -96.4% | 212,291 | -94.5% | 0.04% | -97.4% |
| OVID | OVID THERAPEUTICS INC | $506,000 | +28.1% | 121,950 | 0.0% | 0.01% | -7.7% | |
| ELGXQ | ENDOLOGIX INC | $124,000 | -60.4% | 78,755 | 0.0% | 0.00% | -70.0% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $14,000 | 0.0% | 10,229 | 0.0% | 0.00% | – | |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -16,260 | -100.0% | -0.00% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -10,000 | -100.0% | -0.01% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -75,000 | -100.0% | -0.01% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -3,910 | -100.0% | -0.01% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -2,166 | -100.0% | -0.01% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -2,740 | -100.0% | -0.01% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -16,720 | -100.0% | -0.01% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -21,630 | -100.0% | -0.01% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB LTD | $0 | – | -14,700 | -100.0% | -0.01% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -7,182 | -100.0% | -0.01% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -490,340 | -100.0% | -0.23% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -3,235,795 | -100.0% | -0.25% | – |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -749,026 | -100.0% | -0.27% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -3,607,800 | -100.0% | -0.47% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -612,558 | -100.0% | -0.72% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -187,599 | -100.0% | -0.80% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -342,987 | -100.0% | -0.85% | – |
| Exit | ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $0 | – | -25,000,000 | -100.0% | -0.93% | – | |
| XNCR | Exit | XENCOR INC | $0 | – | -879,627 | -100.0% | -0.99% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -297,972 | -100.0% | -1.34% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -304,158 | -100.0% | -1.52% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -2,404,157 | -100.0% | -1.66% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -562,700 | -100.0% | -1.87% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -1,162,200 | -100.0% | -3.81% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -8,244,896 | -100.0% | -5.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.